Healthcare-associated
infections pose a serious risk for patients,
staff, and visitors and are a severe burden on the National Health
Service, costing at least £1 billion annually. Antimicrobial
surfaces significantly contribute toward reducing the incidence of
infections as they prevent bacterial adhesion and cause bacterial
cell death. Using a simple, easily upscalable swell–encapsulation–shrink
method, novel antimicrobial surfaces have been developed by incorporating
metal oxide nanoparticles (NPs) and crystal violet (CV) dye into medical-grade
polyurethane sheets. This study compares the bactericidal effects
of polyurethane incorporating ZnO, Mg-doped ZnO, and MgO. All metal
oxide NPs are well defined, with average diameters ranging from 2
to 18 nm. These materials demonstrate potent bactericidal activity
when tested against clinically relevant bacteria such as Escherichia coli and Staphylococcus
aureus. Additionally, these composites are tested
against an epidemic strain of methicillin-resistant Staphylococcus aureus (MRSA) that is rife in hospitals
throughout the UK. Furthermore, we have tested these materials using
a low light intensity (∼500 lx), similar to that present in
many clinical environments. The highest activity is achieved from
polymer composites incorporating CV and ∼3 nm ZnO NPs, and
the different performances of the metal oxides have been discussed.